189 related articles for article (PubMed ID: 14676204)
1. A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases.
Brdlik CM; Crews CM
J Biol Chem; 2004 Mar; 279(10):9475-80. PubMed ID: 14676204
[TBL] [Abstract][Full Text] [Related]
2. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
[TBL] [Abstract][Full Text] [Related]
3. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
[TBL] [Abstract][Full Text] [Related]
4. Understanding the selectivity of fumagillin for the methionine aminopeptidase type II.
Klein CD; Folkers G
Oncol Res; 2003; 13(12):513-20. PubMed ID: 12899241
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells.
Turk BE; Griffith EC; Wolf S; Biemann K; Chang YH; Liu JO
Chem Biol; 1999 Nov; 6(11):823-33. PubMed ID: 10574784
[TBL] [Abstract][Full Text] [Related]
6. Discovery of natural product ovalicin sensitive type 1 methionine aminopeptidases: molecular and structural basis.
Pillalamarri V; Arya T; Haque N; Bala SC; Marapaka AK; Addlagatta A
Biochem J; 2019 Mar; 476(6):991-1003. PubMed ID: 30837307
[TBL] [Abstract][Full Text] [Related]
7. Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis.
Ehlers T; Furness S; Robinson TP; Zhong HA; Goldsmith D; Aribser J; Bowen JP
Curr Top Med Chem; 2016; 16(13):1478-88. PubMed ID: 26369821
[TBL] [Abstract][Full Text] [Related]
8. Disruption of Wnt planar cell polarity signaling by aberrant accumulation of the MetAP-2 substrate Rab37.
Sundberg TB; Darricarrere N; Cirone P; Li X; McDonald L; Mei X; Westlake CJ; Slusarski DC; Beynon RJ; Crews CM
Chem Biol; 2011 Oct; 18(10):1300-11. PubMed ID: 22035799
[TBL] [Abstract][Full Text] [Related]
9. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
[TBL] [Abstract][Full Text] [Related]
10. Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase.
Addlagatta A; Matthews BW
Protein Sci; 2006 Aug; 15(8):1842-8. PubMed ID: 16823043
[TBL] [Abstract][Full Text] [Related]
11. Microsporidian methionine aminopeptidase type 2.
Weiss LM; Costa SF; Zhang H
J Eukaryot Microbiol; 2001; Suppl():88S-90S. PubMed ID: 11906093
[No Abstract] [Full Text] [Related]
12. A single amino acid difference between archaeal and human type 2 methionine aminopeptidases differentiates their affinity towards ovalicin.
Bala S; Reddi B; Addlagatta A
Biochim Biophys Acta Proteins Proteom; 2023 Feb; 1871(2):140881. PubMed ID: 36396098
[TBL] [Abstract][Full Text] [Related]
13. The anti-angiogenic agent fumagillin covalently modifies a conserved active-site histidine in the Escherichia coli methionine aminopeptidase.
Lowther WT; McMillen DA; Orville AM; Matthews BW
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12153-7. PubMed ID: 9770455
[TBL] [Abstract][Full Text] [Related]
14. Homology modeling and calculation of the cobalt cluster charges of the Encephazlitozoon cuniculi methionine aminopeptidase, a potential target for drug design.
Bontems F; le Floch P; Duffieux F; Biderre C; Peyret P; Lallemand JY
Biophys Chem; 2003 Aug; 105(1):29-43. PubMed ID: 12932577
[TBL] [Abstract][Full Text] [Related]
15. Structure of human methionine aminopeptidase-2 complexed with fumagillin.
Liu S; Widom J; Kemp CW; Crews CM; Clardy J
Science; 1998 Nov; 282(5392):1324-7. PubMed ID: 9812898
[TBL] [Abstract][Full Text] [Related]
16. QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin analogues: another example of an allosteric interaction.
Mekapati SB; Hansch C
Bioorg Med Chem; 2001 Dec; 9(12):3225-30. PubMed ID: 11711298
[TBL] [Abstract][Full Text] [Related]
17. Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression.
Turk BE; Su Z; Liu JO
Bioorg Med Chem; 1998 Aug; 6(8):1163-9. PubMed ID: 9784858
[TBL] [Abstract][Full Text] [Related]
18. Mutations at the S1 sites of methionine aminopeptidases from Escherichia coli and Homo sapiens reveal the residues critical for substrate specificity.
Li JY; Cui YM; Chen LL; Gu M; Li J; Nan FJ; Ye QZ
J Biol Chem; 2004 May; 279(20):21128-34. PubMed ID: 14976199
[TBL] [Abstract][Full Text] [Related]
19. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo.
Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO
Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010
[TBL] [Abstract][Full Text] [Related]
20. Phylogenetic relationships of methionine aminopeptidase 2 among Encephalitozoon species and genotypes of microsporidia.
Pandrea I; Mittleider D; Brindley PJ; Didier ES; Robertson DL
Mol Biochem Parasitol; 2005 Apr; 140(2):141-52. PubMed ID: 15760654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
